Post-approval studies (Phase 4)Study completedNCT01822418
What this trial is testing
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Who this might be right for
SchizophreniaSchizoaffective DisorderDelusional Disorder
Central Institute of Mental Health, Mannheim 27